Test Catalog

Test ID: CMVC8    
Cytomegalovirus (CMV) CD8 T-Cell Immune Competence, Quantitative Assessment by Flow Cytometry, Blood

Useful For Suggests clinical disorders or settings where the test may be helpful

Assessing cytomegalovirus (CMV)-specific immune competence in allo-hematopoietic stem cell transplantation patients who are at risk for developing late CMV disease (beyond day 100 after transplant)  


Assessing CMV-specific immune competence in solid organ transplant patients who are at high risk for CMV reactivation posttransplant


Monitoring immune competence in patients post-primary CMV infection after transplant who are at risk for CMV reactivation after the cessation of antiviral prophylaxis


Identifying individuals who are likely to be protected from posttransplant CMV infection and those who are at higher risk of CMV reactivation


The global CD8 T cell immune competence assay is useful for determining over immunosuppression within the CD8 T cell compartment, when used on transplant recipients and patients with autoimmune disorders receiving therapy with immunosuppressant agents

Special Instructions Library of PDFs including pertinent information and forms related to the test

Method Name A short description of the method used to perform the test

Flow Cytometry

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.


Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

CMV CD8 T-Cell QN by Flow Cytometry

Aliases Lists additional common names for a test, as an aid in searching

CMV (Cytomegalovirus)
Cytomegalic Inclusion Disease (CMID)
Cytomegalovirus (CMV)
CMID (Cytomegalic Inclusion Disease)